South University - NSG 6020 NSG 6420 MIDTERM South University - NSG 6020NSG 6420 MIDTERM South University - NSG 6020NSG 6420 MIDTERM South University - NSG 6020 NSG 6420 MIDTERM South University - NSG

*** **** MIDTERMLatest **** *** ******* ***** 6420 MIDTERMCOPD ***** ************* <70%FEV1</80%*Chronic cough/sputum ************* unaware **** ******** ** ************** ***** ****************** *********** ********* **** ************* *** ****** ********** ************* ***** IIISEVEREFEV1/FVC **** ******* ************* SOBReduced ******** *********************** ************* **** ****** on QOL COPD Stage ****** ************************************ FailureCorPulmonale ********** of JVP *** ******* ***** edema)QOL **** ********************* *** ** life threateningHow **** **** ****************************** ** ********** ************* ******** ** ****** *************** ******************** is ************** ************ **** ************ bronchospasmAsthma Most ****** chronic respiratory ******** among *** *** ******************************* IgE mediated ****** ********* all ******* disorders *** **** I **************** *************** * hypersensitivity reactionImmediate hypersensitivityIgE-mediatedAntigen ***** ** *** **** is ***** to ****** **** ***** *** ***** basophils ********** release ** ********* mediators ********** proteases chemotactic factors) and ********* of ***** ********* (prostaglandins ************ ******************* ****** ***************** vasodilation ********* cap ************ ***** ********************** ********* ********* asthma ******** *************** *********** **** ***** of ********** ********** *** ***** *** **** food ****************** ****** ***** ******** ** antigen Allergic ***** of ***************** eczema *** asthma Samter's ********** ****** ****** *** ASA allergy Most ****** ******* of ********************** **** symptom of **************** ***** ***** ** ** asthmaAKA ***** ******* ************ way ** confirm ****** ************ provocation Intermittent ************************* ********** **************** use </2 *********** ************ with **** *********** exacerbations ********* **** ******** * ****** *** ************ asthmastep ********* asthmaSx>/2days/week *** not ******* ********** 3-4x/monthSABA use >2 ********* *** *** dailyminor ************************ ****** lung ************** FEV1 ** ************************ ***************** ************ asthma **** functionFEV1>80% ************ ************ ****** ****** *********** ********* ******* awakenings: >1x/week *** not *********** **** ********* limitation mod ****** lung ************************ predictedFEV1/FVC reduced 5% Mod asthma ****** 3 and consider **** course ** **** *************** ********* ******* ***** *********** ***** **************** *************** ****** lung ******************* ***************** ******* ************** ****** **** ******** ****** 4 or * *** ******** ***** ****** ** **************** **** 1SABA *********** **** **** **** ******* ******** LTRA ********** ** theophylline Asthma **** **** **** *** * ******* ****** **** *********** **** ******* dose *** * LABA Asthma **** ***** dose *** + *************** ********** for patients **** ***************** step ***** **** *** + **** + **** ************************* omalizumab *** *** **** ***************** ********** for ***** ********** in *** hours ** **** *** until ** ** ********** **** **** **** weekly ***** ** *** ********** *** **** **** ************ *** ** ********* then monthly until ***** control *** at ***** 3 months IDAMCH<23MCV<80Serum **** ******* *********************** ********************* ** ***** test *** ********* cells ** ********** tx1st ***** **** ************* ********* *********** high ** ********* ***** veggies dried **** and ***** *** meat fortified ************************ normochromichgb>1030% ********** ***************** ****** type ** ****** ** ************ pts?ACD ACD ******** or *** ironnorm ************ ******** ************************** *************** ******** ******** ************ RDW Findings ** ***** **** for thalassemiaTEAR DROP ***** ************ *** acanthocytes Blood **** for thalassemia?hgb *************************** ******************** *** *** and ****** deficiency ********** ************ of vit b12 ******************** shiny tongue *********** *** ********** ****************** *********** ********* ****** **** of fine ***** control *********** *** ************** ** folate ****************** *** pallor ***** ******** glossitis ** ****** **** ********** ** ***** SIGNS Foods rich ** ***** acid?bananas ** ***** leafy veggies ********* ***** and cereal foods **** ** vB12?shellfish liver fish ********* cereals and breads *** *** dairy *** meat poultryeggs ************* ** primarily ************ **** superimposed inflammationCOPDInflammation ** cells lining ********* walls hyperplasia ** ****** ****** *** ********* of ***** airwaysChronic *********************** and *********** of inter alveolar septa within *** ******** ********** **** wall *********** ** ******* ** *********************** common ********* ** COPDdyspnea ** exertion COPD ** test?spirometry confirms *************** stage I txSABA ********* stage ** ****** **** * or **** long ****** ********************* ***** *** ****** **** * ** **** LABAs; inhaled ********************* ***** ** ****** plus one ** **** ****** ******* **************** ** ** ***************** ** **** exacerbations?cough ********* in ********* and/or ********* ********* ********** ** sputum/changes ** color ** ********** SOB increases; ** ************************************************** ******* seizures cardiac ** *** ********** **** ************ **** antibiotics *** ************************* *********************** ************** ********** ******** ****************** **** cardiac ** *************** ** **************** ******* s/sxusually ***************** tenderness ** ***************** **** ******* **** ear ****** usually wellWhat ** chronic ****** *************** ********************* otitistopical ************* ************************* * corticosteroid*aminoglycoside * ************** **** ** **** *********** ***** ********** only ********************* ******** yeast) ** ********* ********** *** **************** ****** ************* ***** ***** ** *** ** patients*severe ********* *** *********** *** ********* causing ** ** skull ************ ******** ********** ******** trismus AOM s/sxunwell pyrexia otalgia/discharge **** of ******* of drum and landmarks*Red ******* ********* ******* ************ ***** ************* ****** ************ (20-30%)Mcat (15%) Bullous AOMcover ********** pneumo and ***** ********** for ******* 1st line *********** ** ****** ** ******** *** in last ******************* for PCN allergy BPPVbenign ********** ********** **************** ** ** caused ** **** floating ******* ****** in the ************ ****** ** ******* ******** ****** ******* *** ******* brainstem *********** ******* and ********** ** *********** ******* ******* ***** ******** ******** lasts ******* to *********** *** ********** ******************** ******************* rehab**self-limitingVestibular neuritisLabyrinthitis*Infection ** ***** ear ***** ****** ****** often ********* URI*Affects ********** ******* ** ** ********** BPPV *** ********** neuritis?BPPV: **** ****** **** ***** any *** usually ***** * URI s/sx ** vestibular neuritis?Disabling ******* **** *** **** ********** ******** ******* ******* ************** *** ** ******** for ********** neuritisvestibular rehabusually resolves ** ******* ************ ******* ***** ****** ************** **** emetics anticholinergic *** ***** hrs Meniere's dxPeripheral ********** disorder ********* from ****** ************* pressure; ***** ** ******** separating endolymph *** ********* ***** mixing *** distention ******* vertigo Meniere's dx ****** *********** ** Meniere'ssudden ******** of ******* associated **** TINNITUS AND DIMINISHED HEARING*lasts ******* ** ****** ************ bt **************** ************* *** ********* ******** salt ******** ******** ****** ** **************** **** ********** ***** ****************** *********** * ************ ******************* ******* glaucoma*hard *** *** ******* ***** ****** cornea ******* ********** ****** *********** ** ACG?ACUTEsevere **** HA *********** **** common ** **** **************** ********* *** ************* standard *** ****************** *** ******* **** ***** peripheral *************** ** ** if ***** hour ****** ** *** *** **** **** ****** ********* ** **** ******** ******** ******** ***** and systemic **** ** ******* IOP OAG?Open ***** glaucoma 90% ** ******** cases?OAG OAG **** ****** in ****** **** ****** ** ****** (leading ***** ** *************** in OAG?up ** 22mmHG S/sx ** ************* onset no ***** *** ******************* **** of peripheral visionOptic nerve **** pale **** ********* *** ** **** ********** ********* trabeculoplastySurgery- ******** ***** ** advanced ******** for ***************** ******* *** ************ antagonists **** ***** ******** ******* ********** *** ******** ************* ** influenza?high ***** ********* lasts *** ****** ******* ***** and ***** ******* and weakness *** ** *** ****** ******* exhaustion Contraindications ** flu ********* ******** reaction ************* after previous **** or ** * ******* component ********* *** ************** *** precautionsmod or ****** ***** ******* **** w/o ******** ******** barre syndrome **** * ***** ** ******** *** ******** ****** *** the nasal *** ************ children * ***** ******* * ***** of *** **** ** ** *********** ********* *** ** *** ***** *** ** ***************** ** *********** ** **** vaccine*approved *********************** ** nasal *** ******** ***** ****** **** ******* use **** 2-17)pregnant ************* 2 ***** ******* 4 ***** *** have ****** ** *** **** *** a ******* of ******** in *** **** ** monthsInfluenza ********** ***** in last 48 hoursPpl *** **** *** severely ***************** *** *** ***** ******* *** * ********** ******* ************** ****** (60-70% ** all bacterial CAP) CAP atypical organismsinfluenza ********** chlamydia ********** adenovirus Most common ********** *** ************** ****** mycoplasma ****** ************** hflu ******************* (cpneumoniae) *** resp ************ organisms ** **** abusemoraxellacatarrhalis *** ********************* ********* ** ***** ***************** ******** ******** ********* ** *************** ******* ***** of *** ** any ***** *** *********** *** ******** ** CAPhflu ****************** ****** ******** ** ******** ** ***** ** *** ** ***** ******* than ** *********************** ***** of *** in any ***** age group?spneumoniaes/sx ** ******** ********* ** ******** *** ************ less ill than ***** **** bacterial PNAsx *** **** up ** * wks and ******* *** ******* ********** ******** xraysputum ******** (not ******* *** outpt) CAP tx *** previously ******* pts **** no ************* ******* ** **** 3 ********************* tx for *** **** comorbids?resp *************************** **** a macrolide Most ****** ***** ** pharyngitis?virus (90%) ***** adeno parainflu s/sx ** *************** ****** ***** ****** ***** *********** ******* ** ****** ******** enlarged ******** ******** exudates **** ****** petechiae cervical ********** **** *********** *** ** give ** ***** *********************** *** pharyngitis?Pen * * 500 *** ** TID *** ************ ** ********** ** *** ************** ** ***************** ** ************* of ******************* ***** ****** *********** ********* ***** ************ ** ******* ********** neck ********** ******** ******* **** *************** ******** to ************* ***** no * xray Monoacute ***** pharyngitis caused ** ********* **** *** ********* yrs; ********** ****** 4-6 *********** ** monopharyngitis fever *************** malaise splenomegaly ********* ******** *** rash Labs *** ******* **** ***** ******** ************************* **** ******** **************** **** *** *** ****** ** **** ********** ***** ** *** **** **** pt?q *** weeks; ** contact ****** ** ***** ****** ***** re-evaluated (x1month+) allergic ******** ********** ********* adults)45-64 *** ********** *** *********** ** American adults107% 45-6478% ***** years PE findings *** allergic ************ ** **** *** ***** ****** ***** patency ********** ****** *** ****** ************ ****** mucus ************* ***** and ******** ** ***** mucosa Allergic ******** labs/smears?nasal ****** for eosinophils *************** ********** ******** serum *** ****** **** ******* for allergies Allergic rhinitis *********** avoidance ** ********* **************** ****************** line *** ******** ** ****** ******** ************** medsintranasal *************** *** ******** decongestants *********** ******** antagonist Type * **************** *************** ********* (allergic ****** ******** *************** *********** angioedema ********* latex *** some **** *************** ** type * hypersensitivity ********* occur<1 **** ***** exposure PPD ********** *********** *** ** persons ** **** **** for ********** ******* on xray suggestive ** old ***** with ***** *********** ** other **************** ************* ** ********* *********** contacts ** ppl **** ****** ******* ********** >/10mmRecent ********** (>5yrs) from **** prevalent ********* (asia ****** ********************************** shelterspre-exisiting conditions (wt **** ******* gastrectomy *** ***************** ************* ***** ***** ****** ********** >/15mmALL ************** line tx for ********** ********** ********** ************ ***** *** TB3-4 ***** for * ***** **** 2 **** regimen *** 18 ************** ******* ** ***************** peripheral ********** **** ** ****** *** **** ****************** ******* ** baseline *** ******* ***** *** if ** and ** ***** **** ******* ** ** **** ***** **** ***************** ******* of ***************** ************* ******** ***** *** ********** ********** rash ********* ********** ********************** effects to ****************** ******* ************* effectiveness ****** **** ****** BECOME **************** TB **** ** give ****** pregnancy?PZA *** INHStreptomycin CONTRAINDICATED Stats regarding small cell **** ** and ********* **** **** caSCLC= *** ** all **** ca's * ***** **** **************** 85% ** *** lung cancers   Types of non-small cell **** ca *** statsadenocarcinoma- MOST ****** *********** cell ************ **** ****** ************ cause ** cancer death for both *** *** ***************** **** **** ** ***************** nodes ***** mediastinal) then ***** ******* bone ****** ********** ***** ** **** ** ** ***************** many ppl **** *** ** **** ** / ***************** ** lung ********** **** **** ******* ** **** ******** ****** ******** of ****** *** or ****** ** ***** wheezing ******* ********** ***** ********** ** ********* requirementslow-dose ** ** chest ** ***** ** *** fairly **** health at ***** 30 **** **** hx ** ******* *** still ******* ** have quit **** **** * years- ******** ****** **** *** ** ** **** as ****** ** **** ************** **** ******* symptomsskin: hives uticaria ******** or ******* of ****** dermatitisresp tract: ******** ****** ******** allergic rhinitis ******* *********** ****** ******** diarrhea dysphagia pain What ** oral ******* ****************** ** *** ****** *** ******** ******* **** ******** * ************* ** pollen- ****** **** ****** ******* ***** ************ *** carrots sx of oral ******* syndrome?itching ***** **** ******** ** ******* ** **** ******* of throat *** ** **** NOT *************

Click here to download attached files: docx-(15) (1).docx